| アブストラクト | We reviewed thrombocytopenia (TP) reports to the US Vaccine Adverse Event Reporting System (VAERS). We examined TP patterns for differences in single versus multiple immunization reports, presence of a live viral vaccine, seriousness, age, and interval to symptom onset. We found 1510 reports of possible TP and after exclusions evaluated 1440 for possible causes. Most (1078; 75%) met the regulatory definition of a serious adverse event. TP was reported after inactivated and live viral vaccines. Platelet counts <10x10(9)/L were reported. Identified vaccines could be prioritized for hypothesis-testing studies. |
|---|
| ジャーナル名 | Vaccine |
|---|
| 投稿日 | 2010/12/04 |
|---|
| 投稿者 | Woo, Emily Jane; Wise, Robert P; Menschik, David; Shadomy, Sean V; Iskander, John; Beeler, Judy; Varricchio, Frederick; Ball, Robert |
|---|
| 組織名 | Food and Drug Administration, FDA/CBER/OBE, Rockville, MD 20852, USA.;jane.woo@fda.hhs.gov |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/21126606/ |
|---|
